Form 4: Bio-Key International Director Acquires Shares in Lieu of Board Fees

Robert J. Michel, a director at Bio-Key International, acquired 1,429 shares of common stock on March 27, 2024, as payment for board meeting attendance fees.

Summary

• On March 27, 2024, Robert J. Michel, a director of Bio-Key International, acquired 1,429 shares of the company's common stock.
• The shares were issued under the Issuer's Amended and Restated 2015 Equity Incentive Plan.
• The acquisition was in payment of board meeting attendance fees.
• Following the transaction, Michel directly owns 3,672 shares of Bio-Key International.
• The transaction was reported on March 29, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. A director receiving shares in lieu of cash compensation is a common practice and doesn't necessarily indicate a strong positive or negative outlook.

Positives

• A director taking shares in lieu of cash may signal confidence in the company's future prospects.

Industry Context

Director share acquisitions are common and can be seen as a positive sign, indicating confidence in the company's future. However, the impact is generally small unless the amount is significant.

Related Party Transactions

• The issuance of shares to Robert J. Michel, a director, in payment of board meeting attendance fees is a related party transaction.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it involves a small number of shares.

Key Dates

Keywords

Bio-Key International, BKYI, Robert J. Michel, Director, Share Acquisition, Equity Incentive Plan, Board Fees, Form 4